Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-035773)

Filing Details

Accession Number:: 0001209191-13-035773
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-07-05 13:03:50
Reporting Period:: 2013-06-24

Filing Date:: 2013-07-05
Accepted Time:: 2013-07-05 13:03:50
Original Submission Date:: 2013-07-03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1000694	Novavax Inc	NVAX	Biological Products, (No Disgnostic Substances) (2836)	222816046

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1265801	A Barclay Phillips	9920 Belward Campus Drive Rockville MD 20850	Svp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-06-12	0	$0.00	0	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This Form 4/A is filed to correct the Form 4 fling for Mr. Phillips on July 3, 2013, which was erroneous. Mr. Phillips does not, as of the date of this report, hold any shares of Common Stock.